A Year Reflection of Poltekkes Kemenkes Jakarta III Covid-19 Handling Task Force Through RDT Antibody and Antigen Swab on Suspect Cases
Main Article Content
Abstract
The covid-19 Pandemic affected worldwide including Indonesia and obliged each part of society to handle its spread. The implementation of screening regulations for suspect cases by Polkesjati Covid-19 Handing Task Force had been established for a year since the first day of infection happen. However, the report has never been implemented. This study was conducted to describe a one-year implementation of screening suspect cases in Polkesjati. This study was a narrative-descriptive study using secondary data from polkesjati Covid-19 handling task force. Data were derived from a total of 1,062 respondents of RDT Antibody test and a total of 2,014 respondents undergone an Antigen swab test at age of 16 – 62 from January 2021 – January 2022. The respondents were a student from MLT, Physiotherapy, Midwifery, and Nursing students and employees. RDT Antibody test showed that reactive case was high in February and June 2021, meanwhile, Antigen swab test showed an increasing result from February to April 2021 and gradually decreased in September 2021. The most interesting part was shown from a contact tracing that indicated 7 respondents with a positive antigen test. The lowest portion of antibody and antigen detection indicated the succesfull strategy of task force especially with suspect cases.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Abbott. (2020). COVID-19 Ag Rapid Test Device (Nasopharyngeal). In Abbott (Ed.), Global Point of Care, Abbott.
II. Adji, B. (2020). Lamanya Hasil Tes Swab Jadi Masalah di Daerah.
https://republika.co.id/berita/q98fb5328/lamanya-hasil-tes-emswabem-jadi-masalah-di-daerah. Accessed on September 21st, 2020.
III. Agustina, A. S., & Fajrunni, R. (2020). Perbandingan Metode RT-PCR dan tes rapid antibodi untuk deteksi COVID-19. Jurnal kesehatan Manarang, 6, 47–54.
IV. Alejo, J. L., Mitchell, J., Chang, A., Chiang, T. P. Y., Massie, A. B., Segev, D. L. et al. 2022. Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of Covid-19. JAMA 327(11): 1085–87.
V. ArcGIS. (2021). Gugus Tugas Percepatan Penanganan COVID-19 Republik Indonesia. https://bnpb-inacovid19.hub.arcgis.com/app/indonesia-covid-19-dashboard. accessed on September 21st, 2020.
VI. Caliendo, A. M. & Hanson, K. E. 2022. Covid-19: Diagnosis. https://www.uptodate.com/contents/covid-19-diagnosis#H2607838323. Accessed on October 15th, 2022.
VII. Dinkes. (2021). Informasi dan Peta khusus Sebaran COVID-19 kota Bogor.
http://www.covid19.kotabogor.go.id/. Accessed on September 21st, 2020.
VIII. Dirjen P2P. 2020. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (Covid-19) Revisi Ke-4. Kementerian Kesehatan, Jakarta.
IX. Dyer, O. 2021. Covid-19: Indonesia Becomes Asia’s New Pandemic Epicentre as Delta Variant Spreads. BMJ 374:n1815
X. Haryono, E. & Harsari, A. Y. 2022. Taming Two Waves of The Covid-19 Pandemic: The Case of Indonesia in International Conference on Humanities and Social Science. KnE Social Science: 44–52.
XI. Johansson, M. A., Quandelacy, T. M., Kada, S., Prasad, P. V., Steele, M., Brooks, J. T., Slayton, R. B., Biggerstaff, M., & Butler, J. C. (2021). SARS-CoV-2 Transmission from People Without COVID-19 Symptoms. JAMA network open, 4(1), e2035057.
XII. Satgas Polkesjati. (2021). Laporan bulanan kegiatan satgas. Poltekkes Jakarta III, Jakarta.
XIII. VivaDiag. (2020). COVID-19 IgM/IgG Rapid Test Package Insert.
XIV. World Health Organization. (2021). WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/. accessed on September 21st, 2022.